Immunostains Used to Subtype Hepatic Adenomas Do Not Distinguish Hepatic Adenomas From Hepatocellular Carcinomas

Immunostains are used to subtype hepatic adenomas to stratify for the risk of malignant transformation. The most common panel of immunostains used for this purpose includes liver fatty acid–binding protein (LFABP), serum amyloid A (SAA) protein, C-reactive protein (CRP), and glutamine synthetase (GS...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The American journal of surgical pathology 2016-08, Vol.40 (8), p.1062-1069
Hauptverfasser:	Liu, Liping, Shah, Sejal S, Naini, Bita V, French, Samuel, Wu, Tsung-Teh, Torbenson, Michael S, Chandan, Vishal S
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenoma, Liver Cell - diagnosis Adult Aged Aged, 80 and over Biomarkers, Tumor - analysis Carcinoma, Hepatocellular - diagnosis Diagnosis, Differential Female Humans Immunohistochemistry - methods Liver Neoplasms - diagnosis Male Middle Aged Tissue Array Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!